These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule. McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge. Fraser DG; Leib SR; Zhang BS; Mealey RH; Brown WC; McGuire TC Clin Diagn Lab Immunol; 2005 Aug; 12(8):983-93. PubMed ID: 16085917 [TBL] [Abstract][Full Text] [Related]
10. Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses. Ridgely SL; McGuire TC Vaccine; 2002 Mar; 20(13-14):1809-19. PubMed ID: 11906769 [TBL] [Abstract][Full Text] [Related]
11. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus. Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779 [TBL] [Abstract][Full Text] [Related]
12. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors. Lonning SM; Zhang W; Leib SR; McGuire TC J Virol; 1999 Apr; 73(4):2762-9. PubMed ID: 10074123 [TBL] [Abstract][Full Text] [Related]
13. Response of ELA-A1 horses immunized with lipopeptide containing an equine infectious anemia virus ELA-A1-restricted CTL epitope to virus challenge. Ridgely SL; Zhang B; McGuire TC Vaccine; 2003 Jan; 21(5-6):491-506. PubMed ID: 12531649 [TBL] [Abstract][Full Text] [Related]
14. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657 [TBL] [Abstract][Full Text] [Related]
15. Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses. McGuire TC; Leib SR; Lonning SM; Zhang W; Byrne KM; Mealey RH J Gen Virol; 2000 Nov; 81(Pt 11):2735-2739. PubMed ID: 11038386 [TBL] [Abstract][Full Text] [Related]
16. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Mealey RH; Littke MH; Leib SR; Davis WC; McGuire TC Vet Immunol Immunopathol; 2008 Jan; 121(1-2):8-22. PubMed ID: 17727961 [TBL] [Abstract][Full Text] [Related]
17. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100 [TBL] [Abstract][Full Text] [Related]